Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study
In the USA, systemic corticosteroids remain widely prescribed. These findings highlight the critical need for broader adoption of effective corticosteroid-sparing therapies in patients with AD.
Authors
- Christopher G. Bunick (ORCID: https://orcid.org/0000-0002-4011-8308)
- Elvira D’Andrea (ORCID: https://orcid.org/0000-0002-5263-3964)
- Lani R. Wegrzyn
- A. Armstrong
- Emma Yue
- Mark Lebwohl
- Madhi Saranadasa
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of California, Los Angeles (US)
- AbbVie (United States) (US)
- Yale University (US)
- Mount Sinai Hospital (US)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2026-02-22
- DOI
- https://doi.org/10.1007/s13555-026-01667-4
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00